Tuyu Zheng
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Ependymoma group-specific blood-brain barrier differences uncovered by a multi-omics approach.
Journal: Scientific reports
Published: August 29, 2025
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling.
Journal: Acta neuropathologica communications
Published: August 21, 2025
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma.
Journal: Neuro-oncology
Published: July 11, 2025
Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.
Journal: Nature genetics
Published: December 06, 2024
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling.
Journal: Acta neuropathologica communications
Published: October 23, 2024
Dominant Malignant Clones Leverage Lineage Restricted Epigenomic Programs to Drive Ependymoma Development.
Journal: bioRxiv : the preprint server for biology
Published: August 30, 2024
Dominant clones leverage developmental epigenomic states to drive ependymoma.
Journal: Nature
Published: August 09, 2024
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.
Journal: Acta neuropathologica
Published: April 28, 2021
ZFTA Translocations Constitute Ependymoma Chromatin Remodeling and Transcription Factors.
Journal: Cancer discovery
Published: July 16, 2020
Primary cilia sensitize endothelial cells to BMP and prevent excessive vascular regression.
Journal: The Journal of cell biology
Published: June 27, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026